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Internalization of some plasma membrane constituents, bacterial toxins, and viruses occurs via caveolae; however, the
factors that regulate caveolar internalization are still unclear. Here, we demonstrate that a brief treatment of cultured cells
with natural or synthetic glycosphingolipids (GSLs) or elevation of cholesterol (either by acute treatment with m-
cyclodextrin/cholesterol or by alteration of growth conditions) dramatically stimulates caveolar endocytosis with little or
no effect on other endocytic mechanisms. These treatments also stimulated the movement of GFP-labeled vesicles in cells
transfected with caveolin-1-GFP and reduced the number of surface-connected caveolae seen by electron microscopy. In
contrast, overexpression of caveolin-1 decreased caveolar uptake, but treatment with GSLs reversed this effect and
stimulated caveolar endocytosis. Stimulation of caveolar endocytosis did not occur using ceramide or phosphatidylcho-
line and was not due to GSL degradation because similar results were obtained using a nonhydrolyzable GSL analog.
Stimulated caveolar endocytosis required src kinase and PKC- activity as shown by i) use of pharmacological inhibitors,
ii) expression of kinase inactive src or dominant negative PKC, and iii) stimulation of src kinase activity upon addition
of GSLs or cholesterol. These results suggest that caveolar endocytosis is regulated by a balance of caveolin-1, cholesterol,
and GSLs at the plasma membrane.
INTRODUCTION
Caveolae are plasma membrane (PM) specializations that
are rich in cholesterol, sphingolipids, and caveolin-1 (Cav1),
a cholesterol-binding protein (Smart et al., 1999). By electron
microscopy, they appear as flask-shaped structures at the
PM and as smooth uncoated vesicles near the PM. Caveolae
have been implicated in signaling, endocytosis, transcytosis,
and potocytosis (for reviews see Smart et al., 1999; Fielding
and Fielding, 2001; Mineo and Anderson, 2001; Carver and
Schnitzer, 2003; Parton, 2003). Recently caveolae have
gained attention because they have been documented to
play a role in the cellular uptake and intracellular delivery of
some bacterial toxins, viruses, and bacteria (Lencer et al.,
1999; Shin et al., 2000; Norkin, 2001; Pelkmans et al., 2001;
Richterova et al., 2001; Duncan et al., 2002; Marjomaki et al.,
2002). One of the first markers to be used for caveolar
endocytosis was the cholera toxin B subunit (CtxB), which
binds to GM1 ganglioside at the PM and is internalized
through caveolae in some cell types (Orlandi and Fishman,
1998; Torgersen et al., 2001). SV40 virus has been shown to be
internalized from the PM in small Cav1-containing vesicles
(Pelkmans et al., 2001), and caveolar endocytosis of derivat-
ized albumin has also been reported (Schnitzer et al., 1994;
Shubert et al., 2001; Sharma et al., 2003; Singh et al., 2003). We
previously showed that fluorescent glycosphingolipid (GSL)
analogs (lactosylceramide [LacCer] and globoside) are selec-
tively internalized via caveolae in human skin fibroblasts
(HSFs) and other cell types using pathway-specific inhibi-
tors and colocalization with endocytic markers and DsRed-
Cav1 (Puri et al., 2001; Sharma et al., 2003; Singh et al., 2003).
Although the internalization of various markers through
caveolae can be demonstrated, the molecular machinery
underlying caveolar endocytosis is not fully described and
the essential components required for caveolar uptake are
unclear. For example, some studies suggest that Cav1 over-
expression negatively regulates uptake through caveolae
(Minshall et al., 2000; Le et al., 2002), whereas our own
studies showed that internalization of BODIPY-LacCer
through caveolae is stimulated by increased Cav1 expres-
sion (Singh et al., 2003). In addition, the rates of internaliza-
tion and the subsequent endocytic itinerary of different
caveolar markers can vary markedly (e.g., SV40 vs. fluores-
cent GSLs; Pelkmans et al., 2001, 2002; Sharma et al., 2003;
Singh et al., 2003). These observations raise the possibility
that there may be multiple forms of caveolar endocytosis
(Mineo and Anderson, 2001; Le and Nabi, 2003).
In our previous studies of caveolar endocytosis in HSFs, we
found that CtxB internalization was very robust in cells simul-
taneously labeled with fluorescent LacCer (Puri et al., 2001;
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Singh et al., 2003), but were surprised to find that its internal-
ization in the absence of LacCer was barely detectable on the
same time scale (seconds to minutes at 37°C; unpublished
observations). This led us to consider the possibility that the
addition of LacCer, and perhaps other GSLs, to the PM might
stimulate caveolar uptake. In the current study we test this
possibility as well as the more general hypothesis that caveolar
endocytosis can be modulated by altering the balance of cho-
lesterol, SLs, and Cav1 at the PM. Our data demonstrate that
elevation in cellular cholesterol, or acute treatment of cells with
exogenous natural or synthetic GSLs selectively stimulates
caveolar endocytosis and does so in a src- and PKC-dependent
manner. This study provides insights into the regulation of
caveolar endocytosis and also helps reconcile discrepancies in
the literature concerning the vastly different rates of caveolar
uptake seen for different cargo and the conflicting reports
suggesting that Cav1 can act as either a negative regulator (Le
et al., 2002) or a stimulator of endocytosis (Singh et al., 2003).
MATERIALS AND METHODS
Lipids, Fluorescent Probes, and Miscellaneous Reagents
BODIPY-LacCer(Martin and Pagano, 1994) and the nondegradable(Albrecht
et al., 1995) analog, BODIPY-Lac-S-Cer (Puri et al., 2003), were synthesized as
described. Nonfluorescent synthetic lipids, d-lactosyl-1–1-N-octanoyl-D-
erythro-sphingosine (C8-LacCer), di-C8-phosphatidylcholine, and C8-cer-
amide were from Avanti Polar Lipids (Alabaster, AL). Bovine lactosylceram-
ide and monosialoganglioside GM1 were from Matreya Inc. (State College,
PA). Nonfluorescent lipids were complexed with defatted BSA as described
(Martin and Pagano, 1994) or dissolved in DMSO.
AlexaFluor 594 (AF594)-labeled transferrin (Tfn), dextran, and albumin
were from Molecular Probes (Eugene, OR). Tyrosine kinase (PP2, PP3, herbi-
mycin, and genistein) and Protein kinase C inhibitors (chelerytherine chloride
[CC] and Go¨ 6976) were from Calbiochem (San Diego, CA). Src activation
assay kit was from Upstate (Charlottesville, VA). Unless otherwise indicated,
all other reagents were from Sigma Chemical Co. (St. Louis, MO).
Cell Culture and Transfections
Normal HSFs (GM-5659D; Coriell Institute, Camden, NJ) were grown in
EMEM with 10% FBS; HeLa cells (American Type Culture Collection, Rock-
ville, MD) were grown in DMEM with 10% FBS. Cholesterol levels were
altered by growth in medium containing LPDS and/or an excess of LDL as
described (Martin et al., 1993; Puri et al., 1999) or by incubation with a complex
of m-CD and cholesterol (Christian et al., 1997). Cav1-mRed was generated
by fusion of the mRed construct (gift from R.Y. Tsien) to the C terminus of the
human Cav1 in a pcDNA 3.1 vector. Cotransfection of this construct with
Cav1-GFP resulted in 90% colocalization (unpublished data).
Cells were transfected with DN Eps15-GFP (Benmerah et al., 1999), Cav1-
GFP (Pelkmans et al., 2001), or Cav1-mRed or cotransfected with pDsRed2-
Nuc and DN PKC by electroporation. Briefly cells were trypsinized, pel-
leted, and resuspended in electroporation buffer (128 mM l-glutamine; 2 mM
magnesium acetate; 10 M calcium acetate; 20 mM PIPES, pH 7). DNA (15 g)
was then added to 1–1.5  106 cells in 400 L buffer, incubated for 10 min at
4°C, followed by electroporation using GenePulser Xcell (Bio-Rad Laborato-
ries, Hercules, CA) operating at 400 V and 800 F. The cells were then diluted
and cultured in EMEM including 10% FBS and used in experiments 48–72 h
later.
Incubation with Inhibitors
Cells were preincubated in HEPES-buffered MEM (HMEM) containing PP2
(10 nM), PP3 (10 M), genistein (50 M), herbimicin (1 M), CC (2.5 M), Go¨
6976 (10 nM), or Clostridium dificile Toxin B (100 M) for 1 h at 37°C, or with
nystatin (25 g/ml) for 30 min at 37°C. Inhibitors were present in all subse-
quent steps of the experiments.
Incubation with Fluorescent Lipids and Proteins
Cells were incubated for 30 min at 10°C with 0.5–2.5 M BODIPY-LacCer/
BSA, washed twice with HMEM, and further incubated for 5 min at 37°C,
followed by back-exchange with 5% DF-BSA (6 times for 10 min at 10°C) to
remove any fluorescent lipid remaining at the PM after endocytosis (Martin
and Pagano, 1994; Chen et al., 1997). For labeled proteins, cells were preincu-
bated with 5 g/ml AF594-Tfn or 50 g/ml AF-594 albumin for 30 min at
10°C, further incubated for 5 min at 37°C, and acid-stripped (Singh et al., 2003)
to remove labeled protein remaining at the cell surface. For fluid phase
uptake, cells were incubated with 1 mg/ml AF594-dextran for 5 min at 37°C
without preincubation or acid stripping.
Incubation with C8-LacCer and Other Nonfluorescent
Lipids
Cells were incubated with various concentrations of nonfluorescent lipids for
30 min at 10°C followed by internalization for 5 min at 37°C as described for
fluorescent lipids and proteins. The exogenous lipids were added from a
complex with DF-BSA (Martin and Pagano, 1994) or from DMSO and were
present during an initial preincubation step with the fluorescent marker at
10°C as well as during the subsequent incubation at 37°C. In the case of
AF594-dextran, cells were pretreated with the exogenous lipid at 10°C, but
dextran was only present during the 37°C incubation.
Adenoviral Infection
Cells were infected with Ad-Cav1, Ad-KI-src, Ad-DynK44A, or “empty virus”
(Ad-empty) in culture medium at the indicated multiplicity of infection
(MOI). Infection was allowed to proceed for 4 h, followed by washing with
fresh medium and further incubation for 24 h before use. The authenticity of
Ad-KI-src and in vitro studies of src kinase were determined in cell lysates
using a commercial kit (Upstate Biotechnology, Inc., Lake Placid, NY) to
measure phosphorylation of model src peptide substrate.
Microscopy
Fluorescence microscopy was carried out using an Olympus IX70 fluores-
cence microscope and the “Metamorph” image-processing program (Univer-
sal Imaging Corp., Downingtown, PA). In any given experiment, all photomi-
crographs were exposed and processed identically for a given fluorophore.
Intracellular fluorescence was quantified by analyzing images of 10 or more
cells in at least three independent experiments.
Samples were prepared for electron microscopy as described using Ruthe-
nium Red to identify caveolae connected to the cell surface exactly as de-
scribed previously (Parton et al., 2002). The number of caveolae, defined as
uncoated surface invaginations of between 50 and 100 nm in diameter, and
coated pits per cell profile were counted in a double-blind manner with a code
that was only broken after the final quantitation was completed.
RESULTS
Cholesterol Stimulates Endocytosis of Caveolar Markers
HSFs were cultured under various conditions to modulate
cellular cholesterol levels (Martin et al., 1993; Puri et al., 1999)
and subsequently used to study the initial internalization of
BODIPY-LacCer, a marker for caveolar endocytosis (Puri et
al., 2001; Sharma et al., 2003; Singh et al., 2003). Growth in
lipoprotein deficient serum (LPDS) for 3 days resulted in
approximately a 40% reduction in cellular cholesterol and
inhibited the uptake of LacCer by 75–80%, relative to control
cells grown under normal conditions (Figure 1, A and C). In
contrast, when cells were grown in the presence of an excess
of LDL, cellular-free cholesterol was increased twofold rel-
ative to control cells (Martin et al., 1993; Puri et al., 1999,
2003), resulting in about a twofold stimulation of LacCer
internalization. Cholesterol also regulated the internaliza-
tion of albumin (Figure 1C), another marker for caveolar
endocytosis in some cell types (Minshall et al., 2000; Shubert
et al., 2001; Sharma et al., 2003; Singh et al., 2003), in a similar
manner to that seen using BODIPY-LacCer. However, excess
cholesterol did not stimulate the uptake of fluorescent Tfn, a
marker for clathrin-mediated endocytosis (Figure 1C).
In addition to altering cell growth conditions, we also
elevated cellular cholesterol in an acute manner by incubat-
ing HSFs with a complex of methyl--cyclodextrin (m-CD)
and cholesterol (Christian et al., 1997). After this treatment
we stained the cells with filipin, a polyene antibiotic that
fluoresces when bound to cholesterol (Neufeld et al., 1999)
and found an approximately 25% increase in PM fluores-
cence (unpublished data). Treatment of cells with m-CD/
cholesterol stimulated the internalization of BODIPY-LacCer
and AF549 albumin, but had little or no effect on Tfn uptake
(Figure 1, B and C). Together these results demonstrate that
increasing cellular cholesterol by two independent methods
results in a stimulation of the internalization of caveolar
markers with little or no effect on the uptake of a marker for
clathrin-mediated endocytosis.
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GSLs Stimulate Endocytosis of Caveolar Markers
To examine the effect of exogenous GSLs on endocytosis,
HSFs were coincubated with a nonfluorescent, short-chain
analog of LacCer (C8-LacCer) and various endocytic mark-
ers (see MATERIALS AND METHODS). As seen in Figure
2A, 20 M C8-LacCer markedly stimulated the endocytosis
of the caveolar markers, BODIPY-LacCer, and labeled albu-
min as well as CtxB (unpublished data), but had no effect on
the uptake of Tfn, a marker for the clathrin pathway, or on
the uptake of a fluid phase marker, fluorescent dextran.
There was approximately a linear relationship between the
concentration of C8-LacCer (0–20 M) used and the inter-
nalization of BODIPY-LacCer or AF594-albumin, with no
obvious saturation effect (Figure 2B); higher concentrations
of C8-LacCer were not used because they reduced cell via-
bility. Endocytosis of LacCer or albumin was restored to
basal levels when C8-LacCer was removed from the PM by
back-exchange (unpublished data). We also found that a
second incubation with C8-LacCer (added immediately after
the first round of stimulated endocytosis) did not further
stimulate caveolar endocytosis above the level seen after the
initial incubation with this lipid (Figure 2C). The stimulation
of uptake by C8-LacCer was not due to its degradation as
shown by lipid extraction and analysis (unpublished data).
Furthermore, similar results were obtained using a nonde-
gradable thio analog of LacCer (Albrecht et al., 1995; Puri et
al., 2003; Figure 2D). We also screened a number of other
lipids to learn whether they could also stimulate caveolar
endocytosis (Figure 2D). Treatment of HSFs with naturally
occurring LacCer or GM1 ganglioside increased the internal-
ization of fluorescent albumin to a similar extent as that seen
using C8-LacCer. Interestingly, short-chain analogs of cer-
amide or phosphatidylcholine had no effect on this uptake.
Exogenous GSLs or Cholesterol Do Not Induce
Endocytosis by an Alternate Mechanism
In a previous study we showed that BODIPY-LacCer internaliza-
tion was Cav1-dependent in multiple cell types and colocalized
with DsRed-Cav1 after a short period of endocytosis (Puri et al.,
2001; Sharma et al., 2003; Singh et al., 2003). To determine whether
exogenous GSLs or cholesterol altered the mechanism of internal-
ization of caveolar markers such that they became internalized by
an alternate endocytic mechanism, we studied the localization of
BODIPY-LacCer in HSFs that were expressing Cav1-mRed. Ex-
tensive colocalization (80–95%) of BODIPY-LacCer with Cav1-
mRed was seen in punctate structures at short times of endocy-
tosis (e.g., 30 s at 37°C), both in the absence and presence of
C8-LacCer (Figure 3A). Interestingly, this colocalization was re-
duced to 10–20% at a 2-min time point (unpublished data), sug-
gesting that BODIPY-LacCer rapidly exits the Cav1-positive com-
partment. This result is in contrast to our previous study in which
90% overlap was seen between BODIPY-LacCer and DsRed-
Cav1 at the 2-min time point in rat fibroblasts (Singh et al., 2003).
This difference could be due to the reduced tendency of mRed to
oligomerize (Campbell et al., 2002), to the position of DsRed (N-
terminus) vs. mRed (C-terminus) relative to Cav1, or to the dif-
ferent cell types studied. Further evidence that treatment with
exogenous GSLs did not alter the mechanism of endocytosis was
provided by Cav1 RNAi studies. BODIPY-LacCer and albumin
internalization were each inhibited 80–90% by Cav1 RNAi under
both stimulated and unstimulated conditions in HSFs (unpub-
lished data).
We also investigated the effect of various inhibitors that
block different mechanisms of endocytosis on the stimulated
uptake (Figure 3B). In control cells that were not coincu-
bated with C8-LacCer, albumin uptake was dynamin- and
Figure 1. Cholesterol positively regulates the uptake of caveolar
markers. HSFs were (A) grown under various conditions to obtain
cells with low (“depleted”), normal (“control”), or elevated (“ex-
cess”) levels of cholesterol or (B) were briefly incubated at 10°C 
m-CD/cholesterol to increase PM cholesterol (see MATERIALS
AND METHODS). The cells were then incubated with various
concentrations (e.g., 5, 2, or 0.6 M in A) of BODIPY-LacCer for 30
min at 10°C to achieve “equal labeling” of the PM. Samples were
then incubated for 5 min at 37°C to initiate endocytosis, chilled to
10°C, and back-exchanged with DF-BSA to remove any fluorescent
lipid remaining at the PM (see MATERIALS AND METHODS), and
observed under the fluorescence microscope. Bars, 10 m. (C) HSFs
were pulse-labeled with BODIPY-LacCer as in A and B, or with
AF594 albumin or AF594-Tfn, and endocytosis was quantified by
image analysis. The concentrations of fluorescent albumin or Tfn to
achieve “equal loading” of the PM were determined empirically by
image analysis. After a subsequent endocytic pulse (5 min at 37°C),
noninternalized fluorescence was removed by acid stripping before
image analysis to quantify uptake. All values are normalized to
untreated control samples. At least 15 cells were quantified for each
condition in three or more independent experiments.
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nystatin-sensitive, but was not affected by dominant nega-
tive (DN) Eps15 (blocks clathrin internalization; Benmerah et
al., 1999) or by Clostridium dificile toxin B (Toxin B) (broad
range Rho GTPase inhibitor that inhibits fluid phase endo-
cytosis and phagocytosis; Aktories et al., 2000; Sabharanjak et
al., 2002). Virtually identical results were obtained when
C8-LacCer was coincubated with albumin, except that the
absolute amount of albumin uptake (in the absence of inhib-
itors) was stimulated about twofold. Namely, the stimulated
uptake of albumin continued to be dynamin- and nystatin-
sensitive, but was unaffected by DN Eps15 or Toxin B.
Control experiments were carried out to verify that DN
Eps15 inhibited internalization of AF549-Tfn and that Toxin
B inhibited fluorescent dextran uptake under the incubation
conditions used (unpublished data and Sharma et al., 2003;
Singh et al., 2003). Similar results to those with C8-LacCer
were also obtained in cells treated with m-CD/cholesterol,
except that the stimulation of albumin uptake by cholesterol
(in the absence of inhibitors) was somewhat less than that
seen using C8-LacCer (Figure 3B). BODIPY-LacCer internal-
ization exhibited the same sensitivities to inhibitors as
AF594 albumin, both with and without stimulation (unpub-
lished data).
Thus under both unstimulated and C8-LacCer- or choles-
terol-stimulated conditions, i) BODIPY-LacCer colocalized
with fluorescent protein tagged Cav1, and ii) AF594 albumin
and BODIPY-LacCer showed the same spectrum of sensitiv-
ities to various endocytic inhibitors, similar to that observed
in our previous studies of BODIPY-LacCer in unstimulated
cells and consistent with uptake via caveolae.
Figure 2. Pretreatment of HSFs with C8-LacCer stimulates the uptake of fluorescent albumin or BODIPY-LacCer, but not fluorescent dextran
or Tfn. (A) HSFs were coincubated with 20 M C8-LacCer/BSA or BSA alone (Control) and the indicated fluorescent marker for 30 min at
10°C, washed, and further incubated for 5 min at 37°C (see MATERIALS AND METHODS). Samples were then cooled to 10°C and
back-exchanged (for BODIPY-LacCer) or acid-stripped before fluorescence microscopy. Bar, 10 m. (B) Experiments were performed as in
A except that the concentration of C8-LacCer was varied. Internalization of indicated marker after 5 min at 37°C was quantified by image
analysis. Values are expressed as % relative to control cells that were not treated with C8-LacCer. (C) Cells were incubated through a first
round with 1 M BODIPY-LacCer without () or with () 20 M C8-LacCer for 30 min at 4°C followed by 5 min at 37°C as in A. Samples
were then rinsed and incubated through a second round (30 min at 4°C followed by 5 min at 37°C) with or without 20 M C8-LacCer. For
incubations without C8-LacCer, cells were incubated with vehicle alone (i.e., 20 M BSA). (D) Stimulation of albumin uptake by C8-LacCer
vs. other lipids. HSFs were coincubated as in A with the indicated natural or synthetic lipid (20 M) and the internalization of AF594-albumin
evaluated after 5 min at 37°C. Results in B and C are expressed as % internalization relative to control cells. Values are mean  SD (20 cells
for each experimental condition; 3 independent experiments).
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Exogenous GSLs Stimulate Movement of Cav1-GFP
GFP-tagged Cav1 has previously been shown to be rela-
tively immobile at the PM of cells, suggesting that Cav1 is
trapped and immobilized at stable, membrane-associated
caveolae (Thomsen et al., 2002). In the present study, we
transfected HSFs with Cav1-GFP and acquired images at or
near the cell surface every second. In the absence of C8-
LacCer treatment, movement of the Cav1-GFP was rela-
tively slow and many of the fluorescent puncta appeared
immobile during the time course of the observations (1
min). In striking contrast, Cav1-GFP puncta became highly
mobile upon stimulation with C8-LacCer, and many of the
fluorescent puncta disappeared from the plane of focus,
suggesting they had been internalized from the PM. This
movement was analyzed in several different ways and is
shown in Figure 4 and in Supplemental Data. Similar results
were obtained when cells were treated with m-CD/choles-
terol (unpublished data).
Effect of Cav1 Overexpression and Exogenous GSLs on
Caveolar Endocytosis
To examine the effect of Cav1 expression on caveolar endocy-
tosis, we used HeLa cells, which have lower levels of Cav1 than
HSFs (Torgersen et al., 2001; Singh et al., 2003) and fewer
caveolae at the PM (unpublished data). Cells were infected
with Ad-Cav1 at various MOI for 24 h and then uptake of
AF594 albumin (5 min at 37°C) was quantified. With increasing
MOI, albumin uptake gradually decreased (Figure 5A), consis-
tent with previous studies showing that Cav1 is a negative
regulator of endocytosis (Le et al., 2002; Le and Nabi, 2003).
Interestingly this effect was reversed and the uptake of albumin
was significantly stimulated above control values when cells
were incubated in the presence of C8-LacCer (Figure 5A). In
contrast, when BODIPY-LacCer was used as a marker for
caveolar internalization, we found that infection with Ad-Cav
stimulated uptake of the fluorescent marker (Figure 5B). This
stimulation was further enhanced when C8-LacCer was also
present during the incubations (Figure 5B). We also performed
a quantitative double-blind analysis of surface caveolae levels
by electron microscopy under several of the conditions noted
above (Figure 5C). As expected, infection with Ad-Cav1 caused
Figure 3. Pretreatment with C8-LacCer or m-CD/cholesterol does
not alter the mechanism of albumin internalization in HSFs. (A) HSFs
were transfected with Cav1-mRed and incubated for 30 min at 10°C
without (control) or with C8-LacCer in the presence of 1 M BODIPY-
LacCer. The cells were then rinsed and further incubated for 30 s at
37°C, cooled to 10°C, and back-exchanged with defatted BSA as in
Figure 1 to remove any BODIPY-LacCer that was not internalized.
Cav1-mRed and BODIPY-LacCer were then imaged in red and green
channels, respectively. Bar, 2 m. (B) Cells were untreated (no inhibi-
tor) or treated with C8-LacCer/BSA or m-CD/cholesterol as in Fig-
ures 1 and 2, and the uptake of AF594-albumin was quantified after 5
min of internalization at 37°C. To assess the mechanism of internaliza-
tion, cells were pretreated with nystatin, Clostridium dificile Toxin B,
transfected with DN Eps15-GFP, or infected with Ad-DynK44A. Data
are expressed relative to the value obtained in the absence of inhibitors
for the untreated Control sample. Note that pretreatment with C8-
LacCer or m-CD/cholesterol stimulated albumin uptake, but did not
affect the inhibition (or lack of inhibition) by the various inhibitors.
Values are mean  SD (10 cells for each experimental condition; 5
independent experiments).
Figure 4. C8-LacCer stimulates the movement of Cav1-GFP. HSFs
were transfected with Cav1-GFP and incubated for 30 min at 10°C
without (Control) or with C8-LacCer. The samples were then
warmed to 37°C and fluorescence images acquired every second for
1 min. See Supplemental Data. (A) Sequential frames were rendered
in pseudocolor (frame 1, green; frame 2, red) and then merged.
Yellow puncta indicate immobile structures, whereas green and red
puncta indicate Cav1-GFP that has moved between frames. Note the
high fraction of yellow puncta in the Control cells relative to the
C8-LacCer–treated sample. (B) Successive frames were examined
as in A and the % of fluorescent puncta in the overlay images which
were immobile (i.e., yellow) was quantified.
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an increase in density of caveolae at the cell surface. Interest-
ingly, treatment with C8-LacCer decreased the number of sur-
face-connected caveolae regardless of whether the levels of
Cav1 were increased by Ad-Cav1 viral infection (Figure 5C). In
the same cells, there was no significant difference in clathrin-
coated pit density under all the conditions tested (unpublished
data). On the basis of these results, we suggest that in HeLa
cells, increasing Cav1 by itself does not stimulate caveolar
endocytosis (i.e., reduce the number of surface connected
caveolae) unless additional GSLs are also added to the PM.
Src Kinase and PKC Are Required for GSL or
Cholesterol Stimulation of Caveolar Endocytosis
To obtain further information on the mechanism by which
LacCer stimulates caveolar endocytosis, we examined the
effect of several inhibitors of src kinase and PKC, two
kinases that have been shown to be involved in the regu-
lated internalization through caveolae (Smart et al., 1995;
Mineo et al., 1999; Mineo and Anderson, 2001). As shown in
Figure 6A, two src kinase inhibitors, herbimycin and PP2,
blocked the endocytosis of fluorescent albumin in intact
cells, with or without stimulation by C8-LacCer or m-CD/
cholesterol, whereas PP3, a negative control for PP2, had no
effect on albumin uptake. Genistein, a more general tyrosine
kinase inhibitor, also inhibited both the stimulated and un-
stimulated internalization of albumin.
We also examined the stimulated endocytosis of fluorescent
albumin or BODIPY-LacCer in HSFs which were infected with
an adenovirus expressing a Kinase Inactive src (Ad-KI-src) and
found that both the unstimulated and the C8-LacCer- or m-
CD/cholesterol-stimulated uptake of AF594 albumin (Figure 6,
B and C) and of BODIPY-LacCer (Figure 6C) were inhibited.
Interestingly, when src kinase activity was measured in cell
lysates by measuring the phosphorylation of a src kinase pep-
tide substrate, there was10-fold increase in src activity using
cells pretreated with C8-LacCer and 8-fold increase in src
activity using cells pretreated with m-CD/cholesterol relative
to untreated controls (Figure 6D). Little stimulation was seen in
control samples in which C8-LacCer was added to the cell
lysate rather than to intact cells, or in cell lysates after infection
with Ad-KI-src (unpublished data).
Similarly, chelerytherine chloride (CC) and Go¨ 6976, gen-
eral and specific inhibitors of PKC, inhibited albumin inter-
nalization, with or without C8-LacCer or m-CD/choles-
terol treatment (Figure 6A). In addition, we transfected cells
with DN PKC and found that AF594 albumin internaliza-
tion was inhibited in the transfected cells and that this
inhibition was not affected by treatment with C8-LacCer or
m-CD/cholesterol (Figure 6B). Together, these results
demonstrate a requirement for both src kinase and PKC in
the stimulation of caveolar uptake by C8-LacCer or m-CD/
cholesterol and show that src activity is greatly increased by
the addition of these lipids.
DISCUSSION
In this study we examined caveolar endocytosis in cultured
fibroblasts and show that internalization through caveolae is
Figure 5. Cav1 overexpression attenutates caveolar endocytosis in
HeLa cells, but this effect is overcome by treatment with C8-LacCer.
(A) Cells were infected with Ad-Cav1 at various MOI for 24 h. The
cells were then incubated with AF594 albumin without (E) or with
C8-LacCer/BSA (F) for 5 min at 37°C as in Figure 2, and the uptake
was quantified by image analysis. All values are relative to the
uptake obtained in the absence of C8-LacCer treatment using cells
that were not infected with Ad-Cav1. (B) Cells were incubated with
Ad-Empty or Ad-Cav1 virus at an MOI of 30 for 24 h and then
incubated with AF594 albumin or BODIPY-LacCer as in Figure 2.
Values for each marker are quantified relative to control values
obtained using cells infected with Ad-empty virus. Values are
mean  SD (10 cells for each experimental condition; 3 indepen-
dent experiments). (C) Cells were infected with Ad-Empty or Ad-
Cav1, followed by incubations with BSA or C8-LacCer/BSA at 10°C.
Samples were then warmed for 5 min at 37°C, fixed, stained with
Figure 5. (continued) Ruthenium Red, and embedded for electron
microscopy. Cells were sectioned parallel to the substratum through
the nucleus and 20 random profiles from different cells were exam-
ined for each treatment in a blinded study. The number of surface
connected caveolae were quantified and plotted for each experimen-
tal condition (see MATERIALS AND METHODS).
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regulated by three essential components: cholesterol, GSLs,
and Cav1. Acute treatment of cells with exogenous GSLs
(natural or synthetic) or elevation of cellular cholesterol
dramatically and selectively stimulated caveolar endocyto-
sis without affecting other mechanisms of internalization.
Consistent with the selective stimulation of caveolar uptake,
treatment with exogenous GSLs or cholesterol markedly
accelerated the movement of Cav1-GFP in living cells and
decreased the number of surface connected caveolae seen by
electron microscopy. No stimulation was observed when
cells were treated with several other classes of lipids, sug-
gesting this phenomenon is restricted to GSLs and choles-
terol. These findings provide new insights into the regula-
tion of caveolar endocytosis and are discussed below.
Regulation of Caveolar Endocytosis by Cholesterol, Cav1,
and GSLs
Results from the current study suggest that a balance among
cholesterol, GSLs, and Cav1 levels is important in regulating
caveolar endocytosis. i) In the case of cholesterol, we found that
endocytosis of two caveolar markers (labeled albumin or flu-
orescent LacCer) was increased when cells were grown under
conditions that elevate free cholesterol by about twofold (Mar-
tin et al., 1993; Puri et al., 1999, 2003) or when PM cholesterol
was increased acutely by incubation with m-CD/cholesterol
(Figure 1). No such effect was seen using fluorescent Tfn, a
marker for clathrin-mediated endocytosis. In contrast, and as
shown previously by others, cholesterol depletion reduced the
number of caveolae at the PM and reduced the internalization
of caveolar markers (Figure 1 and Hailstones et al., 1998; Dreja
et al., 2002). ii) In the case of GSLs, we found that an acute
treatment of cells with natural LacCer or GM1 ganglioside, or
with synthetic short-chain C8-LacCer selectively and dramati-
cally stimulated the uptake of fluorescent albumin and
BODIPY-LacCer, but did not affect internalization of markers
internalized by fluid phase or clathrin-mediated endocytosis
(Figure 2). Consistent with a stimulation of caveolar endocyto-
sis, we observed that treatment of HSFs with C8-LacCer en-
hanced the movement of Cav1-GFP–labeled vesicles at or near
the PM, relative to untreated cells in which such vesicles were
relatively immobile (Figure 4 and Supplemental Data). We also
found that incubation of HeLa cells with C8-LacCer reduced
the number of surface connected caveolae seen by electron
microscopy (Figure 5C), presumably reflecting an increase in
internalization of vesicles derived from caveolae. This result
may explain our inability to stimulate a second round of caveo-
lar uptake by the immediate addition of a second bolus of
C8-LacCer (Figure 2C) because the number of caveolae at the
PM available for internalization is reduced by the first treat-
ment with LacCer. iii) In the case of Cav1, we found that increas-
ing Cav1 levels (by infection with Ad-Cav1) decreased caveolar
uptake of albumin in HeLa cells, consistent with the findings of
others who have shown that overexpression of Cav1 acts as a
Figure 6. C8-LacCer or m-CD/cholesterol stimulation of endo-
cytosis in human skin fibroblasts is dependent on src and PKC-.
(A) Uptake of AF594 albumin (5 min at 37°C) was assessed in the
absence or presence of the src kinase inhibitors, PP2 (PP3 is a
negative control for PP2), herbimycin, or genestein, or the PKC
inhibitors, chelerytherine chloride (CC) or Go¨ 6976. Values are
expressed as % of uptake in untreated control cells. (B) Inhibition
of stimulated endocytosis by Ad-KI-Src and DN-PKC-. Cells
were infected with Ad-empty or Ad-KI-src for 24 h or cotrans-
fected with DsRed-Nuc and DN-PKC- (cells outlined in white)
for 24 h. Samples were subsequently incubated with or without
C8-LacCer or m-CD/cholesterol and AF594-albumin for 5 min
at 37°C as in Figure 2. Bar, 10 m. (C) Quantitation of inhibition
of stimulated endocytosis by Ad-KI-Src. Cells were infected with
Ad-KI src or Ad-empty for 24 h and subsequently treated with
C8-LacCer or mCD/cholesterol (see Figures 1 and 2). Internal-
ization of AF594-albumin or BODIPY-LacCer internalization
Figure 6. (continued) (5 min at 37°C) was then quantified by
image analysis. (D) C8-LacCer and cholesterol stimulate src kinase
activity. Cells were infected with Ad-KI src or Ad-empty and sub-
sequently treated with C8-LacCer or mCD/Cholesterol as C. Cells
were then lysed and src kinase activity was quantified by measuring
the phosphorylation of a src peptide substrate (see MATERIALS
AND METHODS). In A and C, values are the means SD (10 cells
per experimental condition; 3 independent experiments). In D, val-
ues are means  SD, expressed as fold stimulation over basal
measurements obtained for Ad-empty infected cells without C8-
LacCer or cholesterol treatment.
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negative regulator of caveolar uptake (Le et al., 2002; Le and
Nabi, 2003). Interestingly, incubation with C8-LacCer (Figure
5A) reversed this effect and actually further stimulated caveo-
lar internalization (Figure 5A).
Our finding that BODIPY-LacCer is internalized through
caveolae within seconds (Puri et al., 2001; Sharma et al., 2003;
Singh et al., 2003) seems to be in contradiction to observations
using other markers for caveolar endocytosis that are internal-
ized very slowly through caveolae (e.g., SV40 virus, folate
receptor; Mineo and Anderson, 2001; Pelkmans et al., 2001).
However, this difference in internalization rates could be
readily explained if BODIPY-LacCer, a GSL analog, stimulates
its own internalization. Indeed this seems to be the case from
the data in Figure 5B, where it was shown that infection of
HeLa cells with Ad-Cav1 inhibited albumin internalization but
stimulated the uptake of BODIPY-LacCer (Figure 5B). Further-
more, both albumin and BODIPY-LacCer uptake were in-
creased in Ad-Cav1–infected HeLa cells when these markers
were incubated with C8-LacCer (Figure 5B). This is also con-
sistent with the stimulation of CtxB uptake seen in the presence
of BODIPY-LacCer (unpublished observations). Thus, it seems
likely that BODIPY-LacCer stimulates caveolar endocytosis in
a manner analogous to C8-LacCer.
Another important point concerns the itineraries of
BODIPY-LacCer and SV40 virus after their internalization
from the PM. Although both agents are taken up through
caveolae (i.e., they have similar sensitivities to cholesterol,
dynamin, and src kinase, and both initially colocalize with
Cav1), their subsequent fates are very different. Namely,
BODIPY-LacCer is rapidly transported to EEA1-positive
early endosomes (Sharma et al., 2003) and then moves to the
Golgi apparatus in a rab7- and rab9-dependent manner
(Choudhury et al., 2002). In contrast, SV40 virus is not asso-
ciated with early endosomes, but rather is delivered to the
endoplasmic reticulum from caveosomes (Pelkmans et al.,
2001). One potential explanation for this discrepancy is that
BODIPY-LacCer initially enters the caveosome but is rapidly
sorted to early endosomes in a process that is stimulated by
cholesterol or GSLs. This possibility could be examined in
the future by simultaneously monitoring the transport of
labeled virus and BODIPY-LacCer in the same cell over time.
Models for Stimulation of Caveolar Endocytosis by
Exogenous GSLs or Cholesterol
Stimulation of caveolar endocytosis by cholesterol or exog-
enous GSLs required src kinase and PKC activity. This was
shown by use of (i) pharmacological inhibitors and (ii) ex-
pression of a kinase inactive src or DN PKC (Figure 6).
These results are consistent with the literature showing that
one or more tyrosine kinases play roles in caveolar endocy-
tosis or other aspects of caveolae function (Mineo et al., 1999;
Minshall et al., 2000; Li et al., 2001; Mineo and Anderson,
2001; Wang et al., 2002). Importantly, in the current study we
found that GSLs or cholesterol significantly stimulated src
kinase activity, suggesting that stimulation of caveolar en-
docytosis by these lipids occurs via activation of src kinase.
A number of previous studies have shown that long-term
addition of exogenous GSLs or overexpression of GSL syn-
thases can increase src activity (Li et al., 2001; Duchemin et
al., 2002; Wang et al., 2002); however, effects on caveolar
endocytosis were not assessed in those studies.
A major question posed by the current study concerns the
mechanism by which addition of GSLs to the PM initiates a
signaling process that stimulates caveolar uptake. We propose
two alternate models that might be tested in future studies. In
both of these, it is assumed that the exogenous GSLs are
present only in the external leaflet of the PM bilayer. It is also
assumed that transbilayer movement of these GSLs does not
occur and that their degradation is not required for triggering
uptake by caveolae. The former assumption is based on studies
with a fluorescent LacCer analog showing that it requires en-
docytosis for internalization (Puri et al., 2001) and that it can be
completely removed from the cell surface by back-exchange
with BSA (unpublished data). The latter assumption is sup-
ported by our observation that a nonhydrolyzable thio-LacCer
analog (Albrecht et al., 1995; Puri et al., 2003) also stimulates
caveolar uptake of albumin.
In the first model we propose that addition of GSLs to the
outer leaflet of the PM may cause a specific interaction of the
GSL with a particular PM protein. This in turn could initiate
a cascade of signaling events resulting in stimulation of
caveolar endocytosis. In this model the GSL could interact
with surface proteins either as a ligand or as a modifier of
the protein environment. The data in Figure 2C demonstrate
that with a second addition of C8-LacCer no further stimu-
lation of caveolar uptake is observed. This data is consistent
with a model in which the C8-LacCer exerts an effect on a
specific membrane protein(s).
An alternative and more complicated scenario is that ad-
dition of GSLs to the outer leaflet of the PM bilayer could
induce changes in the distribution and organization of lipids
in both leaflets of the PM. Such a reorganization (e.g., clus-
tering) of the lipids could induce a redistribution of lipid-
modified signaling proteins on the inner leaflet of the PM.
Coupling of the inner and outer leaflets of the lipid bilayer
has been documented in artificial membranes (Edidin, 2003)
and this phenomenon is also thought to occur at the PM of
living cells, based on the localization of various lipid an-
chored proteins at the PM (Prior et al., 2001; Zacharias et al.,
2002). If such a coupling occurs, changes in inner leaflet
protein localization could lead to the activation of kinases
(e.g., src or PKC) at the PM and initiate caveolar endocytosis.
Indeed, recently it has been demonstrated that rac distribu-
tion is dependent on cholesterol/GSL domains at the PM
(del Pozo et al., 2004).
In summary, our results may have important implications
at both a basic and applied level. First, the observation that
cells respond to increases in PM GSLs and cholesterol by
inducing selective endocytosis of these constituents through
caveolae suggests that cells are able to monitor the PM lipid
composition and adjust it by regulating endocytosis. Second,
caveolae have been proposed as potential sites for selective
delivery of pharmaceuticals (e.g., to vascular endothelial
cells, or lung alveolar cells; Carver and Schnitzer, 2003;
Gumbleton et al., 2003). The regulation of caveolar internal-
ization by modifying GSLs or cholesterol may thus be useful
in further developing such strategies.
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